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Résumé 
 
La méthylation de l'ADN est une marque épigénétique importante chez les mammifères. 
Malgré le fait que la méthylation de la cytosine en 5' (5mC) soit reconnue comme une 
modification épigénétique stable, il devient de plus en plus reconnu qu'elle soit un processus 
plus dynamique impliquant des voies de méthylation et de déméthylation actives. La 
dynamique de la méthylation de l'ADN est désormais bien caractérisée dans le développement 
et dans le fonctionnement cellulaire des mammifères. Très peu est cependant connu concernant 
les implications régulatrices dans les réponses immunitaires. Pour se faire, nous avons effectué 
des analyses du niveau de transcription des gènes ainsi que du profilage épigénétique de 
cellules dendritiques (DCs) humaines. Ceux-ci ont été faits avant et après infection par le 
pathogène Mycobacterium tuberculosis (MTB). Nos résultats fournissent le premier portrait 
génomique du remodelage épigénétique survenant dans les DCs en réponse à une infection 
bactérienne. Nous avons constaté que les changements dans la méthylation de l'ADN sont 
omniprésents, identifiant 3,926 régions différentiellement méthylées lors des infections par 
MTB (MTB-RDMs). Les MTB-RDMs montrent un chevauchement frappant avec les régions 
génomiques marquées par les histones associées avec des régions amplificatrices. De plus, nos 
analyses ont révélées que les MTB-RDMs sont activement liées par des facteurs de 
transcription associés à l'immunité avant même d'être infecté par MTB, suggérant ces 
domaines comme étant des éléments d'activation dans un état de dormance. Nos données 
suggèrent que les changements actifs dans la méthylation jouent un rôle essentiel pour 
contrôler la réponse cellulaire des DCs à l'infection bactérienne. 
 
Mots-clés: Epigénétique, méthylation de l'ADN, modifications des histones, dynamique de la 
chromatine, régions amplificatrices, infection bactérienne, inflammation, bacille de Koch 
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Abstract 
 
DNA methylation is an important epigenetic mark in mammals. Although methylation at the 
5’ position of cytosine (5mC) is recognized as a stable epigenetic modification, it is becoming 
increasingly viewed as a more dynamic process that involves both active methylation and 
demethylation pathways. While the dynamics of DNA methylation has been well characterized 
in mammalian development and normal cellular function, little is known about its regulatory 
implications in immune responses. To that end, we performed comprehensive transcriptional 
and epigenetic profiling of primary dendritic cell (DC) samples from humans, before and after 
infection with Mycobacterium tuberculosis (MTB). Our results provide the first complete 
genomic portrait of the extensive epigenetic remodeling occurring in primary DCs in response 
to a bacterial infection. We found that active changes in DNA methylation are pervasive, 
identifying 3,926 MTB-induced differentially methylated regions (MTB-DMRs). MTB-DMRs 
show a striking overlap with genomic regions marked by histones associated with enhancer 
activity. ATAC-seq footprinting analysis revealed that regions that change methylation were 
actively bound by immune-related TFs prior to MTB-infection suggesting that these domains 
are likely to represent enhancer elements in a poised state. Our data suggests that active 
changes in DNA methylation play an essential and previously unappreciated role at controlling 
of the regulatory programs engaged by DCs in response to a bacterial infection. 
 
Keywords: Epigenetics, DNA methylation, histone modifications, chromatin dynamics, 
enhancers, bacterial infection, inflammation, Mycobacterium tuberculosis  
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1 Introduction 
 
1.1 Epigenetics 
Despite the fact that every cell in a given multicellular organism contains the same genetic 
information, each cell exhibits different functions and morphologies. Knowing the nucleotide 
sequence alone is only a small part of the puzzle and that the answer lies in the epigenetic 
regulation of genes. To understand epigenetics requires an understanding of chromatin 
structure. DNA is packaged into a highly organized and repeated protein-DNA complex called 
nucleosomes, which form chromatin. In addition, our genome is embellished with many 
covalent modifications, which together make up our “epigenome”. These alterations are called 
epigenetic because they do not involve mutations in the underlying DNA sequence. DNA 
methylation and post-translational modifications of core histones are the best-known forms of 
epigenetic process (see Figure 1.1). Combination of these modifications characterizes the 
chromatin configuration and the accessibility of the DNA to the transcription machinery and 
thus, governs the transcriptional regulation of the expression of genes (Fischle, 2008; Cedar 
and Bergman, 2009). In the past few decades, significant progress has been made toward our 
understanding of the importance of epigenetic mechanisms in a wide range of biological 
processes such as organism development and disease progression. 
 
 
  
2 
 
 
Figure 1.1 Schematic of epigenetic markers involved in gene regulation. The two most 
studied components of the “epigenetic code” are DNA methylation and histone tail 
modification. http://www.thermoscientificbio.com/applications/epigenetics/ (2014) 
 
1.2 DNA methylation 
DNA methylation is the covalent addition of a methyl group to the fifth carbon of the cytosine 
base that leads to the formation of 5-methylcytosine (5mC). 5mC has been known to be 
associated with a transcriptionally repressed chromatin state, particularly in long-term gene 
silencing. In 1979, McGhee and Ginder compared the methylation status of a single beta-globin 
locus between cells that did and did not express this gene (McGhee and Ginder, 1979). At that 
time, they used restriction enzymes to distinguish between methylated and unmethylated DNA. 
They showed that the beta-globin locus is essentially unmethylated in cells that expressed beta-
globin. In addition, adding different chemicals that destroyed methyl groups such as, 5-
azacytidine, often turned such genes back on. Shortly after this pioneering work, 5-Aza-2'-
deoxycytidine has been shown to severely inhibit the action DNA methyltranferases to 
normally methylate DNA cytosine residues (Jones et al., 1983). Using this chemical product, 
scientists compared cells before and after treatment to see how the loss of methylation impacts 
  
3 
gene expression by looking at changes in cellular phenotypes. These experiments inspired 
investigators to better understand how exactly DNA methylation impacts gene expression. For 
the past years, DNA methylation has been extensively studied for its role in various biological 
processes including genomic imprinting, inactivation of one X chromosome in females, 
suppression of mobile genetic elements, stem cell differentiation and embryonic development. 
Moreover, aberrant methylation leads to cancerous growth and several other diseases. 
 
1.3 Patterns of global methylation in mammals 
Patterns of DNA methylation vary among different organisms. In mammals, DNA methylation 
occurs predominantly at CpG (cytosine-phosphate-guanosine) dinucleotides but is also found 
at non-CpG sites at a much lesser extent (Lister et al., 2009; Laurent et al., 2010; Hon et al., 
2013; Ziller et al., 2013). Overall, mammalian genomes are very rich in DNA methylation with 
the exception of regions called CpG islands (described below). 
 
1.3.1 CpG islands 
The most prominent feature of DNA methylation is found within CpG islands (CGIs) near 
transcription start sites (TSS) of genes. CGIs are stretches of DNA that have a higher CpG 
density than the rest of the genome but are commonly devoid of methylation (Bird et al., 1985). 
Computational analysis estimated 28,890 CGIs in our genome (Lander et al., 2001), which are 
highly conserved between mice and humans (Deaton and Bird, 2011). Interestingly, the 
majority of gene promoters, particularly of housekeeping genes, reside within CGIs (Gardiner-
Garden and Frommer, 1987; Saxonov et al., 2006; Illingworth et al., 2010). The location and 
preservation of CGIs throughout evolution strongly suggests that these regions possess a 
functional importance. 
Significant evidence indicates that CGIs have been evolutionarily conserved to 
promote gene expression by modulating the chromatin structure and transcription factor (TF) 
binding. One of the common features of CGIs is that they contain more permissive chromatin 
than other stretches of DNA and therefore promote gene expression (Tazi and Bird, 1990; 
Ramirez-Carrozzi et al., 2009; Choi, 2010). Despite their lack of common promoter elements 
(i.e., TATA boxes), CGIs enhance the accessibility of DNA and promote TF binding. 
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Furthermore, there have been many findings of strong inverse correlations between promoter 
activity and DNA methylation, suggesting that promoter methylation exert a regulatory 
function on gene activity. This is best exemplified in the process of genomic imprinting where 
methylation at CpG islands results in stable silencing of gene expression (Li et al., 1993; 
Kaneda et al., 2004). In cancer phenotypes, abnormal gains of methylation in normally 
unmethylated promoter CpG islands of tumor suppressor genes lead to stabilization of 
transcriptional repression and loss of gene function (Jones and Baylin, 2002; Robertson, 2005). 
CGIs also undergo differential methylation and regulate gene expression during development 
and differentiation (Weber et al., 2007; Fouse et al., 2008; Meissner et al., 2008). 
 
1.3.2 Gene body 
As mammalian genomes are globally methylated at CpG sites, it is not surprising that DNA 
methylation is also found across the gene. The ubiquity of DNA methylation makes it difficult 
to assess whether DNA methylation is targeted in a specific manner or if it’s the default state 
of CpG dinucleotides. Cytosine methylation in the promoter region of genes represses 
transcription and yet the bodies of active genes are extensively methylated. Indeed, there has 
been evidence suggesting that DNA methylation of the gene body is associated with a higher 
level of gene expression in dividing cells (Ball et al., 2009; Aran et al., 2011). Also, in X 
chromosome inactivation studies, Hellman and Chess compared the DNA methylation levels 
on the active (Xa) and inactive (Xi) X chromosomes and found reduced methylation 
specifically over gene bodies on Xi (Hellman and Chess, 2007). On the other hand, in 
postmitotic cells such as the brain, gene body methylation is not associated with increased gene 
expression (Guo et al., 2011). As there is increasing evidence that methylation of DNA in 
promoters suppresses gene expression, the role of gene body methylation still remains unclear. 
Recently, Maunakea et al. showed that a number of methylated CpG islands are located 
in intragenic and intergenic regions using RNA markers of transcription initiation and histone 
markers (Maunakea et al., 2010). By further separating CGIs into intragenic and intergenic 
categories, they found that intragenic CGIs are especially prone to methylation, supporting the 
role of intragenic methylation in regulating alternative promoter activity. Another hypothesis 
is that gene body methylation enhances accurate splicing of pre-mRNA supported by the 
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experimental data showing a higher level of methylation in exons compared to introns and that 
spliced exons tend to display lower levels of methylation (Maunakea et al., 2013). Gene body 
methylation also potentially plays a role in silencing repetitive DNA elements (i.e., LINE, Alu, 
etc.) (Yoder et al., 1997). CpG sites in these repetitive regions are largely methylated and are 
believed to be suppressing their transposition activity. 
 
1.3.3 Intergenic 
The potential association of DNA methylation beyond promoters, more specifically at distal 
regulatory regions, has been overlooked because of many reported abnormal changes in CpG 
island methylation situated in cancer patients. Distal regulatory elements (enhancers, silencers 
and insulators) are short regions of DNA of low CpG density located at variable distances from 
the TSS of genes. These regions are found almost exclusively within regions of accessible 
chromatin and play a key role in increasing or decreasing transcription of target genes. Recent 
genome-wide analyses document strong anti-correlation between transcription factor and 
coactivator binding and DNA methylation density (Lister et al., 2009; Stadler et al., 2011; 
Neph et al., 2012) at enhancer. Moreover, these regions are neither methylated nor 
unmethylated but exhibit a more variable methylation illustrating that DNA methylation at 
regulatory elements is much more dynamic than previously appreciated. 
 
1.3.4 Non-CpG methylation 
As previously mentioned, the majority of cytosines in non-CpG context are devoid of 
methylation in mammals. Although this preference of methylation towards the CpG context is 
unknown, there is evidence that non-CpG DNA methylation is relatively abundant in oocytes, 
pluripotent embryonic stem cells, and mature neurons (Lister et al., 2009; Xie et al., 2012; 
Lister et al., 2013; Shirane et al., 2013; Guo et al., 2014). However, the function of non-CpG 
methylation remains unclear. Non-CpG methylation is likely to arise from the same family of 
de novo methyltransferases since there are no recorded homologs of Dnmts to methylate non-
CpG cytosines. 
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1.4 Basic mechanism of DNA methylation 
It is clear that understanding how genome-wide methylation patterns are established requires 
elucidating the mechanisms involved in regulating DNA methylation. Thanks to decades of 
research, many of the proteins and mechanisms involved in DNA methylation have already 
been identified. Processes that regulate DNA methylation are essentially broken down into 
three classes: writers, erasers, and readers. Writers are the enzymes that catalyze the addition 
of methyl groups onto cytosine residues. Erasers modify and remove methyl groups. Finally, 
readers recognize and bind to methyl groups to ultimately mediate changes in gene expression. 
 
1.4.1 Writing DNA methylation 
DNA methylation occurs by the addition of a methyl group from S-adenosylmethionine to 
cytosine with the help of DNA methyltransferases (Dnmts) (Schermelleh et al., 2005). As 
shown in Figure 1.2, there are two types of DNA methyltransferase activities in mammals: de 
novo and maintenance methylation, which are achieved by Dnmt1 and Dnmt3 respectively. 
Dnmt1 was the first eukaryotic DNA methyltransferase to be discovered (Bestor et al., 1988). 
Dnmt1 seemed to be responsible only for maintaining methylation after each round DNA 
replication, which led to the assignment of Dnmt1 as a maintenance DNA methyltransferase 
(Bestor, 2000; Goyal et al., 2006). This is supported by findings showing that that Dnmt1 co-
localizes with the replication machinery (Leonhardt et al., 1992; Schermelleh et al., 2007). At 
replication sites, hemimethylated DNA is formed when the newly synthesized unmethylated 
strand pairs with the methylated template strand. Strikingly, while virtually all of methylated 
CpG sites are methylated in both strands, 98% of methylated CHG sites are highly 
asymmetrical with only one of strands being methylated (Lister et al., 2009). This suggests 
that Dnmt1 recognizes its substrate cytosine residue only if a guanine residue is beside it. 
In addition to Dnmt1, the mammalian genome encodes two functional Dnmt3 
methyltransferases, namely Dnmt3a and Dnmt3b. In the late 1990’s, Okano et al. have reported 
both enzymes as de novo Dnmts since they were found to methylate CpG dinucleotides in vitro 
without preference for hemimethylated DNA (Okano et al., 1999). Although Dnmt3a and 
Dnmt3b show considerable functional redundancy in early developmental stages, they have 
different expression profiles in distinct cell types.  Moreover, Dnmt3b appears to be specialized 
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in particular parts of the chromosome as it engages methylation only at the centromeric region 
(Xu et al., 1999). It has also been proposed that there is a possible cooperation between the de 
novo and the maintenance Dnmts (Siedlecki and Zielenkiewicz, 2006). Dnmt3a and Dnmt3b 
may also participate in the maintenance of methylation by restoring methylation at cytosine 
residues which have been overlooked by Dnmt1 during replication.   
There is a third homolog in the Dnmt3 family found only in germ cells, called Dnmt3L 
(DNA methyltransferase 3-like). Although this protein has been shown to not possess 
methyltransferase activity, it is essential as a regulatory cofactor of Dnmt3a and Dnmt3b (Goll 
and Bestor, 2005). The family Dnmt2 cytosine methyltransferases is the most strongly 
conserved among all known cytosine methyltransferase and it is ubiquitously expressed in 
most human and mouse tissues. What makes Dnmt2 of enigmatic nature is that it lacks 
methyltransferase activity and does not seem to act as a regulatory factor like Dnmt3L – mice 
deficient of Dnmt2 does not display any overt phenotype (Siedlecki and Zielenkiewicz, 2006). 
 
 
 
Figure 1.2 Establishment of DNA methylation patterns in mammals. Dnmt3a and Dnmt3b 
function as de novo methyltransferases whereas Dnmt1 is targeted to replication forks to 
introduce methyl groups to cytosines on the newly synthesized DNA strand corresponding to 
the methylated cytosines in the template strand. Image adapted from (Reik et al., 1999). 
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1.4.2 Erasing DNA methylation 
DNA methylation is relatively stable compared with other epigenetic marks such as histone 
modifications. Nevertheless, loss of DNA methylation, or DNA demethylation, has been 
observed in different biological contexts. DNA demethylation is the process of removal of a 
methyl group from nucleotides in DNA and it may take place in a passive or active fashion. 
Passive DNA demethylation takes place in dividing cells. As Dnmt1 maintains DNA 
methylation during cell replication, its absence allows newly synthesized DNA strands to be 
devoid of methylation. Active DNA demethylation occurs via direct removal of a methyl group 
independently of DNA replication and therefore can take place in both dividing and non-
dividing cells. So far, there is no known mechanism in mammalian cells that can cleave the 
strong covalent carbon-to-carbon bond that connects cytosine to a methyl group. Instead, active 
demethylation occurs through a series of chemical reactions that revert 5mC back to C. A series 
of recent discoveries has brought clarity on our understanding of active DNA demethylation. 
Until recently, the only known covalent epigenetic modification on DNA was 
methylation at position 5’ of cytosine. A landmark discovery by Tahiliani et al. was made 
showing that 5mC is oxidized to 5-hydroxymethylcytosine (5hmC) by the enzyme ten-eleven 
translocation (Tet) family proteins (Tahiliani et al., 2009). More importantly, work from the 
same group have shown that Tet proteins and 5hmC may be involved in DNA demethylation 
– overexpression of Tet1 leads to a decrease in 5mC levels. Since the discovery of Tet, 5hmC 
has taken on a new central role in DNA demethylation. Given our current understanding, active 
demethylation involving Tet fall into two groups, which both initially involve active 
modification (AM) of 5mC to generate 5hmC (see Figure 1.3) (Kohli and Zhang, 2013). In 
the process of passive dilution (PD), unmodified C is regenerated through DNA replication 
since Dnmt1 does not recognize 5hmC and therefore cannot maintain it (Inoue et al., 2011; 
Inoue and Zhang, 2011). Alternatively, active restoration (AR) requires further enzymatic 
modification of 5hmC to regenerate unmodified C. Specifically, Tet can further oxidize 5hmC, 
yielding 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) (He et al., 2011; Ito et al., 
2011). 5fC or 5caC is subsequently excised by thymine DNA glycosylase (TDG) generating 
an abasic site as part of the base excision repair (BER) process (Fromme and Verdine, 2004). 
Ideally, AM-AR has the advantage of achieving rapid conversion of 5mC to unmodified C and 
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therefore seems particularly well suited to locus-specific demethylation processes that require 
a rapid response to environmental stimuli. 
 
 
 
Figure 1.3 A complete pathway for dynamic cytosine modifications. 5mC bases are 
introduced by DNA methyltransferase (DNMT) enzymes. 5mC is further oxidized to 5-
hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) 
during active DNA demethylation by Tet family proteins. In the pathway of active 
modification followed by passive dilution (AM-PD), 5hmC is diluted in a replication-
dependent manner to regenerate unmodified C. In the pathway of AM followed by active 
restoration (AM-AR), 5hmC is further oxidized by TET proteins to 5fC and then 5caC, which 
is then excised by TDG and repaired by the BER pathway into an unmodified cytosine, 
generating an abasic site. Image adapted from (Kohli and Zhang, 2013). 
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1.4.3 Reading DNA methylation 
There are potentially multiple ways in which DNA methylation can decrease transcription 
levels or completely turn off genes. One simple way this is accomplished is by directly 
preventing the binding of the transcriptional machinery or transcription factors to their 
respective regions by the methyl groups themselves (Hark et al., 2000; Jaenisch and Bird, 
2003). Alternatively, repression can be achieved via proteins that specifically recognize and 
bind 5mC. The identification of proteins that can read the methylation signal has shed light on 
how DNA methylation play a repressive role in gene expression. The first characterized 
methylcytosine-binding protein family is the methyl-CpG binding domain (MBD) family 
which consists of five members, namely MBD1, MBD2, MBD3, MBD4 and MeCP2. These 
proteins each contain of a conserved MBD domain that confers a high affinity for methylated 
CpG sites (Nan et al., 1993). As illustrated in Figure 1.4, three of these proteins (MeCP2, 
MBD1 and MBD2) also contain a transcriptional repression domain (TRD) that allows these 
proteins to interact with a variety of repressor complexes and participate in methylation-
dependent repression of transcription (Meehan et al., 1989; Nan et al., 1993). As it will be 
discussed in more detail later, TRDs are known to associate with various histone modification 
enzymes and chromatin remodeling complexes. The second family of methyl-binding proteins 
binds to methylated DNA via a zinc-finger domain and is composed of Kaiso, ZBTB4, and 
ZBTB38 (Prokhortchouk et al., 2001; Filion et al., 2006). Finally, there is the family of UHRF 
(ubiquitin-like, containing PHD and RING finger domain) proteins that includes, UHRF1 and 
UHRF2. These are multidomain proteins that bind methylated cytosines via a SET- and RING-
associated DNA-binding domain (Hashimoto et al., 2008; Hashimoto et al., 2009). 
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Figure 1.4 Readers of methylation signal and their potential mechanism in gene 
repression. A) Graphical representation of the domains in the proteins that recognize and bind 
specifically methylcytosines (Bogdanovic and Veenstra, 2009). B) Transcription factor (TF) is 
able to bind to unmethylated cytosine (white circles) whereas methylated cytosines (black 
circles) or methylcytosine-binding domain (MBD) proteins interfere with TF binding. Image 
adapted from (Trzyna et al., 2012). 
 
1.5 Approaches to investigate DNA methylation  
Over the past decade, epigenetics has grown dramatically and rapidly has become an exciting 
theme in genetics and bioinformatics. New methods have emerged to detect and measure DNA 
methylation, making it possible to map methylation patterns genome-wide, at a high-resolution 
and in a large number of samples (Harris et al., 2010; Laird, 2010; Bock, 2012). There are 
three methods commonly used to assess DNA methylation: 1) bisulfite sequencing, 2) bisulfite 
microarrays, and 3) enrichment-based methods. 
 
1.5.1 Bisulfite sequencing 
Methylated cytosine has roughly the same base-pairing characteristics as unmethylated 
cytosine, and is thus indistinguishable by standard sequencing approaches. To overcome this, 
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genomic DNA can be treated with sodium bisulfite (Clark et al., 1994; Clark et al., 2006) 
(Clark et al., 1994). Under appropriate conditions, sodium bisulfite causes the specific 
deamination of cytosine through a sulfonated intermediate, and its conversion to uracil. While 
unmethylated cytosine residues are converted to uracil, methylated cytosine residues are 
protected from this conversion and therefore remains intact. PCR amplification of converted 
DNA replaces the uracil with thymine. A potential issue with bisulfite analysis is that it 
depends on the complete conversion of unmethylated cytosines. It is essential to ensure that 
bisulfite-treated samples have been completely converted before utilizing them in high-
throughput applications. Key advantages of this technology are its comprehensive genomic 
coverage, high quantitative accuracy and excellent reproducibility. Disadvantages include the 
high cost of whole-genome re-sequencing and the difficulty of discriminating between 5mC 
and 5hmC. 
 
1.5.2 Bisulfite microarrays 
Bisulfite treatment in combination with specially designed genotyping microarrays makes it 
possible to measure DNA methylation levels at a preselected fraction of Cs throughout the 
genome. Bisulfite-converted DNA is assayed with two primers, each labeled with a different 
fluorescent dye. One primer is designed to hybridize if the cytosine is methylated (and 
unconverted), whereas the other will only hybridize to a converted sequence. The two primers 
are used in a PCR reaction with a locus-specific methylation-insensitive primer. This approach 
provides less coverage than other array-based methods, and necessitates the development and 
evaluation of a large set of selective primers, thus limiting its utility for de novo genome 
analysis. Bisulfite microarrays are commercially available only for the human genome. It also 
cannot distinguish 5mC from 5hmC. The strength of the technique is that it provides 
quantitative evaluation of specific cytosines and can process many samples in parallel. 
Therefore, this method is well suited to compare a set of known methylated loci among a large 
number of cell lines or individuals to ascertain methylation polymorphisms. 
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1.5.3 Enrichment-based methods 
Methylated DNA immunoprecipitation (MeDIP), involves isolating methylated using an 
antibody directed against 5-methylcytosine (Sorensen and Collas, 2009). After 
immunoprecipitation, the methylated and unmethylated part of the sample can be differentially 
labeled and applied to microarray (MeDIP-chip) or sequenced (MeDIP-seq). The two key 
advantages of enrichment-based methods are the relatively low cost of achieving genome-wide 
coverage (albeit with a low statistical power in CpG-poor genomic regions) and the ability to 
distinguish between different forms of DNA methylation: for example, using antibodies that 
specifically recognize 5hmC but not 5mC. However, these advantages come at the cost of 
relatively low resolution and high susceptibility to experimental biases. 
 
 
Figure 1.5 Bisulfite conversion. The methyl group covalently attached to the 5’position of 
cytosine protects against bisulfite conversion. Unmethylated cystosines are converted to uracil, 
but not methylated cytosine. 
http://www.illumina.com/Documents/products/datasheets/datasheet_dna_methylation_analys
is.pdf (2014) 
 
1.6 Crosstalk between DNA methylation and histone modifications 
Transcription is ultimately regulated by the interaction of multiple epigenetic mechanisms, 
particularly DNA methylation and histone modifications, which cooperate to activate or 
silence gene expression. There is a wide range of different modifications in the carboxy- and 
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amino-terminal tails of histone proteins, including acetylation, methylation, phosphorylation, 
ubiquitylation, and SUMOylation (Berger, 2007).  
Past studies have shown that there is an intrinsic link between DNA methylation and 
the methylated state of histone protein tails: Dnmt3L interacts with unmethylated H3K4 
through its N-terminus and with Dnmt3a through its C terminus (Jia et al., 2007; Ooi et al., 
2007). According to this model, patterns of methylation of H3K4 (including mono-, di- or 
trimethylation – H3K4me) are already established before de novo methylation of the 
embryonic genome by Dnmt3 family. If Dnmt3L recognizes that the histone moiety is 
methylated, Dnmt3 cannot bind and the underlying DNA region is therefore protected from de 
novo methylation. It is important to note however that the relationship between DNA 
methylation and histone methylation can work in both directions: DNA methylation itself can 
serve as a template for histone methylation. During cell division, the conserved methylation 
pattern in the nascent DNA strand helps reconstruct the patterns of H3K4me3 after replication. 
This is supported by the loss of H3K4me3 when CXXC finger protein 1 (Cfp1) protein, a CpG-
binding protein known to be a component of histone methyltransferase complex, is depleted 
(Thomson et al., 2010). 
MeCP2 has been shown to possess a transcriptional repressor domain that binds the 
corepressor mSin3A (Razin, 1998). This corepressor protein constitutes the core of a 
multiprotein complex that includes histone deacetylases (HDAC1 and HDAC2) which in turn, 
removes acetyl groups from lysine and arginine amino acids located in the histone tails (see 
Figure 1.6). Consequently, an increase in the positive charge occurs due to the amine groups 
of lysine and arginine residues in the histone tails. The positively charged histone and the 
negatively charged DNA backbone (due to phosphate ions) encourage high-affinity binding 
leading to condensing of the DNA around the histones and hindering the access of transcription 
factors to the promoter. Overall, this shows the close link between DNA methylation and 
histone modifications in regulating gene expression. 
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Figure 1.6 Transcriptional regulation is achieved through crosstalk between DNA 
methylation and histone modifications. MeCP2 recognizes and binds to methylated CpG 
residues (mCG) and recruits corepressor mSin3A which is a multiprotein complex that 
includes histone deacetylases (HDAC1 and HDAC2). HDACs removes acetyl groups from H3 
or H4 histone tails. Image adapted from (Razin, 1998). 
 
1.7 Dendritic cells in shaping the immune response 
Dendritic cells (DCs) are professional antigen-presenting cells that have a central role in T cell 
activation and in initiation of adaptive immune responses. DCs express a number of pattern 
recognition receptors (PRRs) such as Toll-like receptors (TLRs) which recognize a wide array 
of pathogen-associated molecular patterns (PAMPs) and discriminate between self and non-
self molecules (Kapsenberg, 2003). As immature cells specialized in antigen uptake and 
processing, DCs reside in and traffic through non-lymphoid peripheral tissues, continuously 
surveying the environment for invading microorganisms. As immature DCs capture antigens 
by endocytosis/phagocytosis, they undergo major changes in gene expression programs, 
evolving from immature, antigen-capturing cells to mature, antigen-presenting, T cell-priming 
cells. This process of DC maturation, in general, involves down-regulation of antigen 
internalization, a redistribution of major histocompatibility complex (MHC) molecules from 
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intracellular endocytic compartments to the DC surface, an increase in the surface expression 
of costimulatory molecules, secretion of chemokines and cytokines, and surface expression of 
adhesion molecules and chemokine receptors (Tan and O'Neill, 2005) (see Figure 1.7). 
To present foreign antigens to naïve T cells, DCs must migrate from inflamed or injured 
peripheral tissues to the closest draining lymph nodes through afferent lymphatic vessels. 
Migration of maturing DCs from the periphery into lymphoid tissues are coordinated by 
chemokines that interact with corresponding receptors on DCs (Alvarez et al., 2008). For 
example, immature DCs express CC-chemokine receptor 1 (CCR1), CCR2, CCR5 and CXC-
chemokine receptor 1 (CXCR1) and are attracted to non-lymphoid tissues by their respective 
ligands, which are expressed constitutively or at inflammatory sites. DC maturation results in 
the downregulation of expression of these chemokine receptors and the upregulation of CCR7 
expression. Expression of CCR7 switches DC responsiveness to its ligands, CC-chemokine 
ligand 19 (CCL19) and CCL21, that guide migration to secondary lymphoid organs. 
Maturation of DCs also induces the production of CCL22, CCL17 (i.e. chemokines that attract 
CCR4-expressing T cells), and CCL18. DC production of the chemokine CXCL16, in T cell-
rich areas of lymphoid organs, may also function in promoting interaction between DCs and 
cytotoxic T cells. 
DCs are capable of processing antigens and present peptide in the context of either 
MHC class I or II molecules, which interact with and stimulate cytotoxic T lymphocytes and 
T helper cells, respectively. As DCs mature, they acquire the properties necessary to form and 
transport peptide-loaded MHC complexes to the cell surface. Antigen transport to the cell 
surface coincides with increased expression of costimulatory molecules, such as CD40, CD80 
and CD86 (Tan and O'Neill, 2005). These molecules amplify T cell receptor signaling and 
promote T cell activation. Moreover, the soluble cytokine profile secreted by DCs varies with 
the different stages of DC development and maturation thus influencing the different effector 
functions characteristic of immature vs. mature DCs (de Saint-Vis et al., 1998). A wide variety 
of cytokines may be expressed by mature DCs and the exact cytokine repertoire expressed will 
depend on the nature of the stimulus, maturation stage of the DC and the existing cytokine 
microenvironment. The distinct cytokine patterns released by mature DCs ultimately 
  
17 
determine their Th1/Th2 polarizing capacities. For example, antigens that prime DCs to secrete 
IL-12 will typically induce Th1 differentiation. 
 
Figure 1.7 Dendritic cell maturation upon antigen encounter. Maturation of dendritic cells, 
in response to antigen, leads to the redistribution of MHC class II molecules and MHC–peptide 
complexes from within the endocytic system to the cell surface, the production of several 
cytokines and membrane associated T cell stimulatory molecules, and the remodeling of 
expressed chemokine receptors. These changes allow dendritic cells to migrate to draining 
lymph nodes and induce antigen-specific immune response by activating T cells.   Image 
adapted from (Hackstein and Thomson, 2004). 
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1.8 Research objectives 
Immune responses to infection are characterized by pervasive changes in gene expression with 
host cells mobilizing hundreds of genes involved in immune-related processes. While the 
dynamics of DNA methylation has been well-characterized in mammalian development and 
normal cellular function, little is known about its regulatory implications in the immune 
response. We hypothesized that widespread changes in DNA methylation may influence the 
expression of genes specifically involved in immune responses to Mycobacterium tuberculosis 
(MTB) infection. Our first aim is to identify genome-wide changes in DNA methylation 
between MTB-infected and non-infected dendritic cells (DCs). The second aim is to 
characterize the putative regulatory potential of changes in methylation. The third aim is to 
examine the interplay between DNA methylation and different histone marks. Finally, we aim 
to verify if dynamic DNA methylation is linked to MTB-induced changes in gene expression.
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2 Experimental Approach 
 
2.1 General molecular biology 
 
2.1.1 Sample collection 
Blood samples from 6 healthy donors were obtained from Research Blood Components. A 
signed written consent was obtained from all of the participants. All individuals recruited in 
this study were healthy Caucasian males between the ages of 21 and 55 years old. We decided 
to focus on only one sex to avoid the potentially confounding effects of sex-specific differences 
in gene expression level on response phenotypes (Ranz et al., 2003; Rinn and Snyder, 2005). 
Only individuals self-reported as currently healthy, not under medication, and with no history 
of diseases such as malaria, tuberculosis, cancer, or hepatitis were included in the study. In 
addition, each donor’s blood was tested for standard blood-borne pathogens, and only samples 
negative for all of the pathogens tested were used. 
 
2.1.2 Mycobacterium tuberculosis preparation 
Mycobacterium tuberculosis preparation was performed as described by Barreiro et al. 
(Barreiro et al., 2012). We infected dendritic cells (DCs) with a Mycobacterium tuberculosis 
(MTB) strain expressing green-fluorescent protein (H37Rv). This recombinant strain carries a 
pEGFP plasmid, which encodes a gene that confers resistance to hygromycin and harbors the 
GFP gene under the control of the mycobacterial Phsp60 constitutive promoter. Importantly, 
previous studies have shown (Kremer et al., 1995; Tailleux et al., 2003) that the presence of 
GFP in MTB does not alter growth or virulence of the bacilli under axenic conditions, relative 
to wild-type MTB. M. tuberculosis H37Rv was grown from a frozen stock to midlog phase in 
7H9 medium (BD) supplemented with albumin-dextrose-catalase (ADC; Difco). We tested the 
virulence of the bacteria in the frozen stock by infecting C57BL/6 mice intranasally with 103 
bacilli. After 21 and 42 d, we estimated a load of 107 bacteria in the mice lungs, indicating that 
the bacteria did not lose its natural virulence (Tanne et al., 2009). 
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2.1.3 Isolation and infection of DCs 
Isolation and infection of DCs were performed as described by Barreiro et al. (Barreiro et al., 
2012). Blood mononuclear cells from healthy volunteers were isolated by Ficoll-Paque 
centrifugation. Blood monocytes were purified from peripheral blood mononuclear cells by 
positive selection with magnetic CD14 MicroBeads (Miltenyi Biotech). Monocytes were then 
cultured for 5 days in RPMI 1640 (Invitrogen) supplemented with 10% heat-inactivated FCS 
(Dutscher), L-glutamine (Invitrogen), GM-CSF (20 ng/mL; Immunotools), and IL-4 (20 
ng/mL; Immunotools). Cell cultures were fed every 2 days with complete medium 
supplemented with the cytokines previously mentioned. Before infection, we systematically 
checked the differentiation/activation status of the monocyte- derived DCs by flow cytometry, 
using antibodies against CD1a, CD14, CD83, and HLA-DR. All antibodies were purchased 
from Becton Dickinson. Only samples presenting the expected phenotype for non-activated 
DCs—CD1a+, CD14−, CD83−, and HLA-DRlow — were used in downstream experiments. 
The resulting monocyte-derived DCs were then infected with MTB for 18 hours at a 
multiplicity of infection of 1-to-1. The choice of 18 hours is based on previous work, which 
revealed that the largest number of transcriptional changes following MTB infection could be 
captured at 18 h post-infection (Tailleux et al., 2008). 
 
2.1.4 MethylC-seq 
The MethylC-seq protocol was performed as described by Lister et al. (Lister et al., 2009). 1) 
Bisulfite Conversion. Starting material was 6 ug of DNA spiked with 3 ng of unmethylated 
Lamba DNA. Initial steps incorporated DNA fragmentation, end repair, addition of single A 
base, adaptor ligation, followed by bisulfite conversion via MethylCode™ Bisulfite 
Conversion Kit, Invitrogen. 2) Library Preparation. Illumina’s TruSeq RNA Sample 
Preparation kit v2 was used for the preparation of the libraries. It involves purifying the poly-
A containing mRNA molecules using oligo-dT attached magnetic beads. The cleaved RNA 
fragments are copied into first strand cDNA using reverse transcriptase and random primers. 
Second strand cDNA synthesis follows, using DNA Polymerase I and RNase H. The cDNA 
fragments then go through an end repair process, the addition of a single “A” base, and then 
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ligation of the adapters. The products are then purified and enriched with PCR. Libraries were 
run on the Illumina HiSeq 2000. 
 
2.1.5 RNA-seq 
mRNA-Seq libraries were generated from total RNA with polyA+ selection of mRNA using 
the TruSeq RNA Sample Prep Kit v2 (Illumina, San Diego, CA). Libraries were run on the 
Illumina Hiseq 2000. 
Total RNA was isolated using the miRNeasy kit (Qiagen). Strand-specific libraries were 
prepared using the Illumina Total Stranded RNA Library kit, with the Ribo-Zero Gold, using 
the method specified by the manufacturer. Libraries were run on the Illumina Hiseq 2500. 
 
2.1.6 ChIP-seq 
Samples were crosslinked with 1% w/v formaldehyde for 10 min at room temperature and 
immediately quenched for 5 min with 125mM Glycine at RT. The samples were then sonicated 
using the Bioruptors (Diagenode) and then ChIP DNA prepared using the IP-Star (Diagenode). 
Approximately 1 million cells were used for each ChIP and ~50,000 cells for the Input. The 
following antibodies were used: H3K4me1 (CST, 5326P, 1), H3K4me3 (CST, 9751BC, 7), 
H3K9me3 (MABI, 0318, 13001), H3K27me3 (MABI, 0323, 13001), H3K27ac (Abcam, 
Ab4729, GR119051), and H3K36me3 (MABI, 0333, 12003). ChIP and Input libraries were 
prepared using the Illumina Truseq Nano DNA kit, with alterations including: PCR enrichment 
(14 cycles) prior to size selection and utilizing the PippinPrep (SAGE Science) instead of the 
SPRI method for the size selection (200-400 bp). Libraries were run on the Illumina Hiseq 
2500. 
 
2.1.7 ATAC-seq 
The ATAC-seq protocol was performed as described by Buenrostro et al. (Buenrostro et al., 
2013) starting with 100,000 cells. Cells were lysed using cold lysis buffer (10 mM Tris-HCl, 
pH 7.4, 10 mM NaCl, 3 mM MgCl2 and 0.05% IGEPAL CA-630). Immediately after lysis, 
nuclei were spun at 500g for 10 min using a refrigerated centrifuge. Immediately following the 
nuclei prep, the pellet was resuspended in the transposase reaction mix (25 μL 2× TD buffer, 
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2.5 μL transposase (Illumina) and 22.5 μL nuclease-free water) and let to incubate at 37 °C for 
30 minutes. Directly following transposition the sample was purified using a Qiagen MinElute 
kit. Following purification, we amplified library fragments using 25 uL of 2X NEBnext PCR 
master mix, 0.3 uL of 100X SYBR Green I, 2.5 uL of each Nextera primers index 1 (i7) and 2 
(i5), 10 uL of the transposed DNA, in a final volume of 50 uL using the PCR conditions 
previously described (Buenrostro et al., 2013). To reduce GC and size bias in our PCR, we 
monitored the PCR reaction using qPCR in order to stop amplification before saturation 
(Buenrostro et al., 2013).The libraries were purified using a Qiagen MinElute kit in 20 μL. 
Quality of the libraries was verified on a polyacrylamide gel and Bioanalyser but final 
quantification was done using KAPA Library Quant kit for Illumina Sequencing Platforms. 
Libraries were run on the Illumina Hiseq 2500. 
 
2.2 Bioinformatics analyses 
 
2.2.1 Bioinformatics software 
Bedtools (Quinlan and Hall, 2010)  
bismark (Krueger and Andrews, 2011)  
Bowtie2 (Langmead and Salzberg, 2012) 
Bsseq (Hansen et al., 2012) 
CENTIPEDE (Pique-Regi et al., 2011) 
chromHMM (Ernst and Kellis, 2012) 
DEseq2 (Anders et al., 2013) 
FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) 
GOrilla (Eden et al., 2009)  
HT-seq (http://www-huber.embl.de/users/anders/HTSeq/doc/overview.html) 
Illumina Casava (version 1.8) 
Macs2 (Zhang et al., 2008) 
ngs.plot (Shen et al., 2014) 
Picard (http://picard.sourceforge.net/) 
R (http://www.r-project.org/) 
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Samtools (Li et al., 2009) 
Tophat2 (Kim et al., 2013) 
Trim_galore (http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) 
 
2.2.2 MethylC-seq processing 
MethylC-seq libraries were sequenced using the Illumina HiSeq 2000, following the 
manufacturer’s instructions. The standard Illumina pipeline was used for image analysis and 
base calling. We used the tool trim_galore to trim off adapter sequence incorporated in the read 
and remove bases with a base quality score of 20. The resulting reads were mapped to human 
reference genome (GRCh37/hg19) and lambda phage genome using bismark (with the options 
--bowtie2 -p 12 -N 1), which uses a bisulfite converted reference genome (C-to-T and a G-to-
A) for read mapping. Only reads that had a unique alignment and a minimum number of 
mismatch of one were retained. We removed PCR duplicates from each library and then 
merged the two libraries for the same sample. To obtain methylation evidence for each 
reference CpG, the number of reads for each site that were methylated and coverage which 
refers to the number of reads covering that position were evaluated using bismark methylation 
extractor. The context of each C was determined and each C was classified as CpG, CHH, or 
CHG, where H is either A, T, or C nucleotide. Methylation was estimated for each CpG locus 
using the number of C (methylated) and T (unmethylated) reads (C/C+T). 
 
2.2.3 ChIP-seq and ATAC-seq processing 
ChIP-seq and ATAC-seq libraries were sequenced using the Illumina HiSeq 2000, following 
the manufacturer’s instructions. The standard Illumina pipeline was used for image analysis 
and base calling. We used the tool trim_galore to trim off adapter sequence incorporated in the 
read and remove bases with a base quality score of 20. The resulting reads were mapped to 
human reference genome (GRCh37/hg19). The alignment software Bowtie 2 was used with 
the following options: -p 12 -N 1. Only reads that had a unique alignment and a minimum 
number of mismatch of one were retained. We removed PCR duplicates from each library and 
then merged the two libraries for the same sample. 
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2.2.4 RNA-seq processing 
Non-strand-specific RNA-seq libraries from polyA+ fraction were sequenced using the 
Illumina HiSeq 2000, following the manufacturer’s instructions. The standard Illumina 
pipeline was used for image analysis and base calling. mRNA sequence reads were aligned to 
the human genome reference (GRCh37/hg19) sequence using the TopHat2 software package 
with a TopHat transcript index from RefSeq. We did not removed PCR duplicates from each 
library since these may represent true signal. Strand-specific libraries were processed similarly. 
 
2.2.5 Genome annotation 
Genomic regions were defined based on GRCh37/hg19 coordinates obtained from GREAT 
which uses only a subset of UCSC Known Genes (http://bejerano.stanford.edu/help/ 
display/GREAT/Genes/). We limited our analysis to protein-coding genes. Since genes can 
have multiple RefSeq transcripts, we selected the leftmost transcription start site or rightmost 
transcription end site to associate a single transcript per gene in the positive strand. The reverse 
was done for genes on the negative strand. We defined promoters as regions 2.5 kb upstream 
of the TSS and gene bodies as the transcribed regions from the start to the end of transcription 
sites for each gene. Furthermore, exons are defined as regions from their specific coding start 
and end. Introns are defined as regions from the coding end of an exon to the coding start of 
the next exon. 
 
2.2.6 DC methylation profile 
We merged CpG methylation evidence from both strands and pooled the methylation data from 
both infected and non-infected samples to get a better estimate of methylation levels.  We 
divided each genomic regions (upstream, gene body, downstream) in 20 bins from 5' to 3' end 
of protein-coding genes, and the mean mC/C level within each bin where individual CpG sites 
belong to was determined. Genes on the negative strand were reversed. To obtain mean 
methylation profiles for each genomic region oriented from 5' to 3'. 
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2.2.7 Identification of MTB-DMRs 
The summarized methylation estimates of strand-merged CpG sites were used to identify 
differences in methylation between infected and non-infected samples using the R package 
bsseq. bsseq implements a smoothing method that uses a local likelihood approach to estimate 
the smoothed probability of methylation at each site, taking into account the spatial correlation 
between nearby sites and placing greater weight on sites with higher coverage. We limited our 
analysis to CpG sites with a read depth >= 4 in at least 3 infected and 3 non-infected samples. 
We identified DMRs as regions containing at least 3 consecutive CpG sites that are 
significantly differentially methylated using a paired t-test (|t-statistic| > 3.9 at P = 0.01) and 
exhibited at least a 10% difference in mean methylation levels between treated and untreated 
samples. 
 
2.2.8 Gene ontology (GO) analysis 
We used GOrilla to test for enrichment of functional annotations among genes nearby MTB-
DMRs, using all GREAT genes as a background set. Analysis was done with default 
parameters and results corrected for multiple testing by the method of Benjamini and Hochberg 
to control the false discovery rate. 
 
2.2.9 ChIP-seq data analysis 
We used the MACS2 (model-based analysis of ChIP-Seq) peak-finding algorithm to identify 
regions of ChIP-Seq enrichment over background (broad mode). A false discovery rate 
threshold of enrichment of 0.05 was used for all data sets. The resulting genomic coordinates 
in bed format were further used in ChromHMM for chromatin annotation. The following 
parameters were used: -Xmx20g -jar ChromHMM.jar BinarizeBed hg19 -Xmx2000M -jar 
ChromHMM.jar LearnModel 10 hg19. 
 
2.2.10 Footprinting analysis 
The input for CENTIPEDE included the PWM score, conservation (PhyloP) and ATAC-seq 
counts within ±100 bp of each genomic region matching a motif. 
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2.2.11 Identifying genes differentially expressed after MTB infection 
A python script called HTSeq counts how many reads map to each feature using the output 
BAM file and a GTF file containing genomic structures or features. Non-expressed genes (read 
count = 0 in at least 3 infected or 3 non-infected samples) were discarded. Using the normalized 
counts for each gene, we identified genes whose expression levels were significantly altered 
following MTB infection of DCs using the Bioconductor DESeq2 with cutoffs: absolute log2 
fold change > 1 and 1% false discovery rate (FDR). 
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3 Results 
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3.1 SUMMARY 
 
DNA methylation is an important epigenetic mark in mammals. Although methylation at the 
5’ position of cytosine (5mC) is recognized as a stable epigenetic modification, it is becoming 
increasingly viewed as a more dynamic process which involves both active methylation and 
demethylation pathways. While the dynamics of DNA methylation has been well-
characterized in mammalian development and normal cellular function, little is known about 
its regulatory implications in immune responses. To that end, we performed comprehensive 
transcriptional and epigenetic profiling of primary dendritic cell (DC) samples from humans, 
before and after infection with Mycobacterium tuberculosis (MTB). Our results provide the 
first complete genomic portrait of the extensive epigenetic remodeling occurring in primary 
DCs in response to a bacterial infection. We found that active changes in DNA methylation 
are pervasive, identifying 3,926 MTB-induced differentially methylated regions (MTB-
DMRs). MTB-DMRs show a striking overlap with genomic regions marked by histones 
associated with enhancer activity. ATAC-seq footprinting analysis revealed that regions that 
change methylation were actively bound by immune-related TFs prior to MTB-infection 
suggesting that these domains are likely to represent enhancer elements in a poised state. 
Finally, we found that differentially expressed genes are associated with MTB-DMRs which 
indicates a potential mechanistic link between DNA methylation and gene expression. Our 
data suggests that active changes in methylation play an essential and previously unappreciated 
role at controlling of the regulatory programs engaged by DCs in response to a bacterial 
infection. 
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3.2 INTRODUCTION 
 
An effective immune response requires the coordinated action of numerous cell types in the 
immune system. Dendritic cells (DCs) are innate immune cells present virtually everywhere in 
the body and are in front line of defense against invading microbial agents and other insults 
(Banchereau and Steinman, 1998). DCs typically sense immune challenge through pattern 
recognition receptors, such as Toll-like receptors (TLRs), located on the cell surface or on the 
endosomal/lysosomal compartment. TLRs recognize molecular signatures that are broadly 
shared by pathogens, collectively referred to as pathogen-associated molecular patterns 
(PAMPs) (Medzhitov, 2001; Janeway and Medzhitov, 2002; Medzhitov, 2007). Interaction of 
TLRs with foreign substances activates DCs, leading to their migration to the draining lymph 
nodes where they present antigens to naive T cells and initiate adaptive immunity (Banchereau 
and Steinman, 1998; Cooper, 2009). 
Upon stimulation, DCs undergo pervasive changes in their transcriptional program, 
mobilizing hundreds of genes involved in immune-related processes (i.e., antimicrobial 
peptides, reactive oxygen species, adhesion molecules, cell death, chemokines and cytokines) 
in a rapid and highly choreographed fashion (Smale, 2010; Smale et al., 2014). This is achieved 
with the help of signal-dependent transcription factors (TFs), including NF-κB, STAT, AP-1, 
and interferon regulatory factors (IRFs), which bind to gene regulatory regions of the genome 
where they function to initiate recruitment of various co-activators (Medzhitov and Horng, 
2009; Smale, 2010, 2011). Epigenetic processes, such as histone modifications and DNA 
methylation, are recognized as important permissive or suppressive factors playing an 
important role in modulating the access of TFs to cis-acting DNA regulatory elements by 
regulating chromatin dynamics and therefore have a significant impact in gene expression. 
Recently, significant progress has been made in our understanding of epigenetic control of 
many immune processes, such as in hematopoietic cell development and lineage decisions 
(Broske et al., 2009; Klug et al., 2010; Hodges et al., 2011; Hogart et al., 2012; Schlesinger et 
al., 2013). Similarly, immune responses are subject to epigenetic control to ensure its proper 
function. Using recent epigenomic profiling technologies, a number of studies have highlighted 
the paramount importance of epigenetic mechanisms in the regulation of complex gene 
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expression programs that underlie immune responses (Foster et al., 2007; Barish et al., 2010; 
Ghisletti et al., 2010; Garber et al., 2012; Kaikkonen et al., 2013; Ostuni et al., 2013). 
However, these studies have been focused on dynamics of histone marks and have been 
primarily performed in innate immune cells in mouse models. No attempts have been made 
thus far to map the DC epigenome, particularly patterns of DNA methylation, in humans. More 
importantly, little is still known about the extent of epigenetic remodeling in DCs in response 
to environmental stress. 
The immune system has been a powerful and effective system to study how the 
epigenome impacts gene expression during immune responses. Similar to macrophages, 
activated DCs can serve as a paradigm for dissecting environmentally responsive 
transcriptional control in an experimentally tractable system. In this study, we investigated 
epigenetic changes induced by a pathogenic bacteria, Mycobacterium tuberculosis (MTB), the 
causative agent of tuberculosis (TB) in humans. We chose to work with MTB because it is a 
pathogen of major importance to human health and for which the immunological interactions 
with DCs have been extensively studied (Barreiro et al., 2012).  
To investigate dynamic epigenetic patterns and transcriptional outputs associated with 
bacterial infection, we infected monocyte-derived dendritic cells with a virulent strain of MTB 
for 18 hours. Following infection, we measured both genome-wide methylation levels and 
expression in non-infected and infected DCs using whole-genome bisulfite sequencing 
(MethylC-seq) and RNA sequencing (RNA-seq), respectively. To complement this data, DC 
samples were subjected to chromatin immunoprecipitation sequencing (ChIP-seq) for six 
histone marks (H3K4me1, H3K4me3, H3K27me3, H3K27ac, H3K36me3, and H3K9me3) and 
assay for transposase-accessible chromatin using sequencing (ATAC-seq) for open chromatin 
profiling.  Our study provides unprecedented insight into the transcriptional and epigenetic 
dynamics during bacterial infection in primary dendritic cells. It also offers a unique 
opportunity to explore the epigenetic mechanisms underlying the regulation of immune 
responses against infectious diseases. 
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3.3 RESULTS 
 
Single-base Resolution Mapping of DC Methylome 
We constructed directional bisulfite-treated libraries using standard Illumina protocol for each 
DC sample in both conditions and generated a total of ~8 billion single-end reads by next-
generation sequencing. Seventy-four percent of the reads were uniquely aligned to either strand 
of the reference genome (hg19), achieving a combined average coverage per CpG site of ~10× 
for each sample. We detected approximately 28 million CpG sites in each sample, which 
covers approximately 90% of total CpG sites. Comparison of methylcytosines of biological 
replicates in both conditions revealed a high concordance of CpG methylation status (Pearson 
r of 0.8-0.9; Table S1). Overall, DNA methylation in DCs was found almost exclusively in the 
CpG context with 76% of CpG sites being highly methylated (0.8-1.0 methylation) and only 
less than 1% CpH methylation, consistent with data from other fully differentiated cell types 
(Figure S2A). In line with other reports, methylation is high ubiquitously except near 
transcription start sites (TSS) and CpG islands (Figures S2B, S2C) (Lister et al., 2009; Stadler 
et al., 2011). As expected, hierarchical clustering analysis of the MethylC-seq data, which 
included human hematopoietic, embryonic, fibroblast and prefrontal cortex cells for 
comparison, revealed that the DC methylome was more similar to that of hematopoietic cells 
(Figure S2D).  
 
MTB Infection Induces Genome-wide Active Changes in DC Methylome  
To explore the scope of dynamic DNA methylation during MTB infection, we looked at 
differences in CpG methylation between untreated and MTB-infected DCs in a genome-wide 
scale. We utilized a set of CpG sites with ≥4 sequence coverage in at least half of the DC 
samples for both conditions, sufficient to interrogate ~20 million CpGs. We defined MTB-
induced differentially methylated regions (MTB-DMRs) as regions of 3 or more adjacent CpG 
sites exhibiting a minimal mean difference of CpG methylation level of 0.1 between the two 
groups (p < 0.01; see Experimental Procedures). Overall, we identified 15,904 dynamic 
CpGs distributed across 3,926 discrete DMRs (1,888 hyper- and 2,038 hypomethylated; 
Figure 1A).  Interestingly, most of the MTB-DMRs are small with the majority of the regions 
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comprising of 3 dynamic CpGs (Figure S3A). Hypermethylated DMRs have a mean length of 
137 bp, significantly shorter than for hypomethylated regions (182 bp, p = 6.27 × 10-18, 
Wilcoxon) (Figure 1B). We then mapped the MTB-DMRs to nearby gene annotation to assess 
the genomic distribution of changes in DNA methylation. We associated a total of 1,358 and 
1,423 unique genes to hyper- and hypomethylated regions respectively. Interestingly, the vast 
majority of MTB-DMRs are not located near promoters (7% at -2.5 kb from transcription start 
sites (TSSs)). Rather, these epigenetically dynamic regions are predominantly found several 
kilobases away from TSSs, at CpG-poor intragenic (49%) and intergenic regions (44%) 
(Figures 1C, 1D and 1E). Collectively, these data show that MTB infection induces extensive 
changes in DNA methylation in fully differentiated DCs and that such changes primarily occur 
at putative distal regulatory elements.  
 
MTB-DMRs Have an Enhancer-Associated Chromatin Signature 
To gain a more complete picture of the underlying epigenetic dynamics and to investigate the 
regulatory events during MTB infection, we next collected ChIP-seq data for 6 histone marks 
(H3K4me1, H3K4me3, H3K27ac, H3K27me3, H3K36me3 and H3K9me3) in infected and 
non-infected DCs. Recent advances in epigenomic profiling technologies have allowed the 
identification of chromatin features associated to enhancers. These epigenomic signatures 
include high enrichment of monomethylated K4 on the histone H3 N-terminal tail (H3K4me1) 
(Heintzman et al., 2009) and low enrichment of H3K4me3 compared to promoters. We 
examined the relative enrichments of each histone marks at MTB-DMRs and found that 
proximal and distal DMRs are enriched for H3K4me3hi/H3K4me1lo and 
H3K4me1hi/H3K4me3lo marks, respectively (Figure 2A) suggesting that MTB-DMRs are 
acting as enhancer elements. To further understand the functional significance of MTB-DMRs, 
we generated gene regulatory annotation maps from the panel of ChIP-seq data using the 
hidden Markov model-based ChromHMM chromatin segmentation program (Consortium et 
al., 2012; Ernst and Kellis, 2012). Consistent with the Refseq-based annotation, there are very 
few MTB-DMRs localized to ChromHMM-annotated promoter regions (state 1). An important 
insight enabling the distinction of active enhancers from inactive/poised enhancer elements 
containing H3K4me1, is through the presence (state 2) or absence (state 3) of histone 
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acetylation (H3K27ac).  Interestingly, we found a third type of enhancers which exhibit the 
following specific combination of histone marks: H3K4me1+H3K27ac+H3K4me3 (state 4). 
We found that 41% of all the MTB-DMRs overlap with a putative enhancer region in non-
infected DCs, a 6.4-fold enrichment altogether as compared to genome-wide expectations (p < 
2.2 × 10-16; Figures 2B, 2C). Interestingly, the overlap with active enhancer regions, 
particularly at state 2, becomes even stronger when chromatin states are defined using MTB-
infected DCs (Figure 2C). 
 Previous studies of developmentally dynamic enhancers have shown that enhancer 
activation is associated with mCG hypomethylation of the enhancer, whereas enhancer 
inactivation is associated with enhancer hypermethylation (Gifford et al., 2013; Lister et al., 
2013). We therefore examined chromatin transition states at hyper- and hypomethylated 
regions separately. Regions that show increased CG methylation upon MTB infection does not 
seem to be associated with specific local chromatin modifications (72% of hyper-DMRs). 
Conversely, decrease in methylation resulted in significant changes in chromatin at pre-
existing enhancers, particularly gaining either H3K27ac (4  3) or H3K4me3 marks (3  2). 
At the same time, hypomethylated regions give rise to de novo enhancer regions, represented 
by transitions 8  3 and 8  4 (Figure 2D). Consistent with the transition states above, 
patterns of histone patterns in distal regions that are hypermethylated upon infection are 
identical to those observed in unstimulated conditions (Figure S4), indicating that 
hypermethylation may not necessarily indicate inactivation in these genomic regions, at least 
in a non-developmental context. Also, hypomethylated regions generally gain localized histone 
modifications characteristic of enhancers (H3K4me1 and H3K27ac) as well as H3K4me3 
(Figures 2E). Interestingly, the central sequences within hypomethylated regions are depleted 
of these three histone marks, which may indicate selective nucleosome eviction thorough 
binding of transcription factors and co-activators such as p300 (Ghisletti et al., 2010) after 
MTB infection.  
 A recent genome-wide study in mouse cortical neurons have demonstrated that 
neuronal activity-regulated enhancers recruit RNA polymerase II (RNAPII) and transcribes bi-
directionally a novel class of enhancer RNAs (eRNAs) (Kim et al., 2010). Since 
hypomethylated regions show characteristics of transcriptional activation in an activity-
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dependent manner, this raises the possibility that RNA transcription may occur at these 
enhancer regions. To test that hypothesis, we sequenced total RNA obtained from infected and 
non-infected DCs after ribosomal RNA was depleted. To distinguish possible enhancer-
derived transcripts from mRNA transcripts, we sought evidence of RNA transcription 
specifically at 833 hypomethylated regions located outside of annotated genes. We observed 
dynamic changes in the levels of these enhancer RNAs (eRNAs) upon infection (Figure 2F) 
and synthesis of eRNAs seems to initiate near enhancer centers where perhaps signal-
dependent transcription factors and RNAPII are bound and to proceed bi-directionally. These 
observations indicate that hypomethylated regions are not merely sites where transcription 
factors bind and recruit RNAPII that might subsequently be delivered to promoters, but are 
also sites where RNA synthesis occurs in response to MTB infection. 
 
MTB-DMRs are Bound by Signal-Dependent Transcription Factors 
Gene regulatory regions are usually characterized by DNase I hypersensitivity (Thurman et 
al., 2012; John et al., 2013) or transposase (Tn5) accessibility (Buenrostro et al., 2013) as DNA 
is usually histone-free in gene regulatory regions so transcription factors can bind to these 
regions. To explore the potential regulators of chromatin dynamics during MTB infection, we 
assayed for transposase-accessible chromatin using sequencing (ATAC-seq) (Buenrostro et 
al., 2013). Tn5-accessibility profile in hypermethylated regions is roughly similar after MTB 
infection, consistent with the observed stable chromatin features. In contrast, we observed 
markedly higher Tn5 accessibility densities among hypomethylated regions commensurate 
with the gain of localized histone marks (Figure 3A). This is illustrated in three different 
regions that lose methylation within the genebody of NFKB1. Here all three hypo-DMRs are 
located in intronic regions are classified as enhancers by chromHMM-based gene regulatory 
region annotation and lead to active chromatin conformation (Figure 3B). 
If MTB-DMRs correspond to enhancers controlling inflammatory gene expression, an 
obvious prediction is that they should be enriched for binding sites for stimulus-activated TFs 
required for the deployment of the inflammatory gene expression program, like NF-κB (Rel) 
and interferon regulatory factors (IRF) family members (Taniguchi et al., 2001; Hayden and 
Ghosh, 2008). Bound transcription factors to genomic DNA protect the underlying binding 
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motifs from DNase I cleavage or tn5 transposase accessibility and thereby, creating “genomic 
footprints” (Neph et al., 2012; Buenrostro et al., 2013) that can be used to reliably predict the 
binding of hundreds of TFs. We inferred ~5.8 million footprints from ATAC-seq data for both 
conditions using CENTIPEDE program (Pique-Regi et al., 2011). Hypermethylated regions 
are enriched in footprints containing motifs for IRF and other TFs potentially implicated in 
different roles in immune responses. Once again, since these regions do not exhibit drastic 
changes in their chromatin accessibility, we did not expect any change in TF binding either 
and indeed found so (Figure 3C). Hypomethylated regions in particular are more enriched in 
footprints tied to motifs for NF-κB, which showed the most significant enrichment (p < 2.2 × 
10-16), in addition to IRF. Strikingly, transcription factors NF-κB or IRF, as well as others, do 
not globally show any significant evidence for increased binding after infection (Figure 3C).  
 
MTB-DMRs are Linked to Changes in Expression of Inflammatory Genes 
To gain insight on the global transcriptional dynamics during MTB infection, we performed 
RNA-seq on poly-A fractions on the same samples for which we collected whole-genome 
methylation profiles. Hierarchical clustering shows that infected samples forms a distinct 
cluster from non-infected samples based on their changes in gene expression after MTB 
infection (Figure S5). Using a difference in normalized expression level higher than absolute 
1-fold as a cutoff, we identified 3,637 protein-coding genes that were significantly 
differentially expressed (DE; FDR < 0.01). We next asked whether dynamic DNA methylation 
is implicated in MTB-induced changes in gene expression. To limit arbitrariness in gene 
assignment, we considered only MTB-DMRs that were within ±100 kb from the closest TSS. 
In general, MTB-DMRs are more likely to be associated with genes changing expression after 
infection (28% versus 21% that are expected by chance alone; p = 1.78 × 10-12, chi-squared 
test; Fig. 4A). Notably, we found that DE genes are more strongly linked to hypomethylated 
(p = 2.01 × 10-13, chi-squared test) than hypermethylated regions (p = 0.0015) suggesting that 
loss of methylation has a more pronounced role in directly regulating immune-specific genes. 
Moreover, when compared to a control group consisting of all the DE genes, the set of DE 
genes associated with hypomethylated regions was enriched for up-regulated transcripts at high 
statistical significance (p = 1.88 × 10-14, chi-squared test; Figure 4B). Gene set enrichment 
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analysis further revealed that genes associated with hyper- and hypomethylated regions are 
more over-represented in functional categories relevant in negative and positive regulation of 
immune responses respectively, such as in signaling and  regulation of response to stimulus 
(Figure 4C). Moreover, hyper-DMRs are associated with genes particularly involved in 
negative regulation of biosynthetic and metabolic processes. This strongly suggests that hyper-
DMRs are implicated in down-regulating genes that are involved in negative regulation of 
multiple biological processes since it methylation is generally known as an epigenetic 
mechanism for repression. 
 
3.4 DISCUSSION 
 
In this study, we have generated transcriptomic and epigenomic data in non-infected and MTB-
infected primary dendritic cells by high-throughput sequencing. This allowed, for the first time, 
for assessment of how the methylation landscape of DCs is rapidly modified in response to 
bacterial infection. Our results show that infection of human DCs with MTB leads to a marked 
remodeling of its methylome, with several thousand regions showing significant changes in 
methylation levels upon infection. Interestingly, we show that MTB-DMRs are located in 
regions of low-CpG density far away from TSS and indeed, they show a striking overlap with 
enhancer regions defined by histone marks. Furthermore, MTB-DMRs are associated with a 
large fraction of the genes that are differentially expressed after MTB infection.  
Footprinting analysis revealed that MTB-DMRs are bound by TFs known to play a key 
role in immune responses to infection, such as NF-κB and IRFs. Strikingly, our results further 
indicate that differential methylation did not result to any significant changes in the binding of 
these TFs. Therefore, it is highly conceivable that transcriptional regulators that interact 
indirectly with the DNA sequence are responsible for the observed changes in methylation. 
Indeed, it is known that many transcriptional regulators are positioned to interact indirectly 
with the DNA sequence of some target sites through mechanisms such as tethering (Biddie et 
al., 2011; Neph et al., 2012). Binding of such transcriptional regulators is likely to be missed 
since footprinting assays cannot detect protein-protein interactions. For instance, in 
hypomethylated regions, we found an increase in H3K27ac mark after MTB infection 
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suggesting the recruitment of p300 co-activator in a stimulus-regulated manner. However, 
footprinting assay did not detect any binding evidence for CREB-binding protein (CBP) or 
p300 acetyltransferases consistent with reports showing that CBP/p300 interacts with DNA-
bound TFs (Ogryzko et al., 1996; Martinez-Balbas et al., 1998). The recruitment of co-
activators as well as PolII might also contribute to the opening of the chromatin. Furthermore, 
the fact that TFs are already bound at hypo-DMRs prior to MTB infection strongly suggests 
that hypo-DMRs are maintained in an open chromatin conformation that is easily accessible 
for co-factor binding. This poised state potentially confers an effective and rapid response to 
DCs against MTB infection. Indeed, this is supported by the high levels of H3K4me1 in these 
regions at basal state. In addition, 5-hydroxymethylcytosine has been shown to contribute to 
the poised chromatin signature found at enhancers (Yu et al., 2012). It will be interesting to 
examine whether 5hmC is enriched in hypo-DMRs prior to infection.  
There is mounting evidence that innate immune responses in mammals have the 
capacity to exert immunological memory upon re-stimulation (Quintin et al., 2014; Smale et 
al., 2014). A recent study by Ostuni et al. shows that the stimulation of mouse macrophages 
with different stimuli (e.g., LPS, IFNγ, IL-4) induces the appearance of a few thousand de novo 
putative enhancer regions, coined “latent enhancers”, that were absent in naïve cells (Ostuni et 
al., 2013). More importantly, H3K4me1 marks were found to persist for days in latent 
enhancers when stimulation ceased, which potentially confers the ability to these regions to 
contribute to a faster and stronger transcriptional response to repeated challenges with the same 
stimulus. This study highlights the implication of epigenetic histone modifications in 
mediating innate immune memory. Although 5-methylcytosine has long been regarded as a 
stable marker, recent data, including the data reported herein, shows that 5mC can dynamically 
change in response to various environmental cues (Guo et al., 2011). Indeed, this is supported 
by the recent discovery of Tet (ten-eleven-translocation) proteins as new epigenetic modifiers 
responsible for conversion of 5-methylcytosine to 5-hydroxymethylcytosine  as part of the 
active demethylation process (Bhutani et al., 2011). This opens the possibility that DNA 
methylation can serve as a mechanism for stimulus-induced epigenetic control and long-lasting 
plasticity in innate immune cells. Thus, in addition to histone modifications, epigenetic DNA 
modifications may expand the capacity of such cells to perpetuate transient stimuli into long-
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lasting covalent modifications for future encounters with similar stimuli. Based on our current 
data, it is hard to identify whether changes in DNA methylation remained fixed overtime. 
Although it remains unclear whether transcription factor binding precedes changes in DNA 
methylation, it is hard to pinpoint at which time point during MTB infection is dynamic 
methylation associated with binding or unbinding of TFs and ultimately, to changes in gene 
expression. Further work is therefore required to investigate the implication of DNA 
methylation in innate short-term memory, ideally through time-course experiments. Also, it 
will be imperative to examine whether changes in DNA methylation could be maintained in 
the absence of a sustained stimulation. 
These observations suggest that active and rapid changes in methylation might play a 
critical role in transcriptional regulation of an efficient immune response to infection. Our 
study also provides a comprehensive resource and offer a new framework for testing the role 
of the epigenome in immune responses. We expect that our findings will stimulate future work 
in unraveling the epigenetic mechanisms contributing to immune responses associated with 
other infectious diseases or immune challenges. 
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Figure 1. DC Methylome is Dynamically Remodeled during MTB Infection 
(A) Smoothed methylation values (y-axis) for 6 MTB-infected samples (red) and 6 non-
infected samples (blue) showing an example of a hyper- (up) and a hypomethylated region 
(down; gray shading). Genomic coordinates of MTB-DMRs are indicated on top. Thick lines 
represent the average methylation for each condition.  
(B) Boxplots comparing the distribution of genomic sizes in base pairs (bp) of hyper- and 
hypomethylated regions. 
(C) Refseq annotation of MTB-DMRs.  
(D) Distribution of distances (bp) of MTB-DMRs to nearest genes in log2 (down) and in linear 
forms (up; in kilobases).  
(E) Distributions of CpG densities of 250-bp windows flanking MTB-modified CpGs and all 
and CpGs in the human genome. 
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Figure 2. MTB-DMRs Have Chromatin Characteristics of Enhancers 
(A) Composite plots of patterns of histone marks, 5 kb around midpoints of proximal (left) and 
distal (right) MTB-DMRs.  
(B) Chromatin state annotation of MTB-DMRs using chromHMM. The number code 
annotation of the chromatin state map is as follows: 1) promoter, 2) strong enhancer 
(H3K4me1+H3K27ac+H3K4me3), 3) strong enhancer (H3K4me1+H3K27ac), 4) weak 
enhancer (H3K4me1), 5) transcription, 6) repressed state 1, 7) repressed state 2 and, 8) 
heterochromatin or no signal.  
(C) Relative enrichment of ratio of MTB-DMRs in non-infected and MTB-infected states, 
compared with the representation of chromatin states genome-wide.  
(D) Chromatin transition states at hyper- (left) and hypo-DMRs (right). The x- and y-axis 
represent chromatin states before and after infection respectively. 
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(E) Composite plots of patterns of histone marks before and after MTB infection, 3 kb around 
midpoints of hypo-DMRs.  
(F) Profile of RNA expression based on ribo-minus RNA fractions at intergenic hypo-DMRs, 
in log2(infected/non-infected). (+) and (-) denote transcripts in forward and reverse strands 
respectively. 
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Figure 3. MTB-DMRs are Enriched for Immune-Specific Transcription Factor 
Footprints 
(A) Tn5-accessibility profiles before and after MTB infection, 3 kb around midpoints of  
MTB-DMRs.  
(B) Chromatin dynamics at 3 separate hypo-DMRs (indicated by arrows) within NFKB1 
genebody, shown by normalized ChIP-seq (H3K4me1, H3K27ac, and H3K4me3) and 
chromHMM tracks. ChIP-seq tracks in blue and red represent non-infected and MTB infected 
states respectively. 
(C) Enrichment of transcription factor footprints associated with hyper- and hypo-DMRs, 
before and after MTB infection. 
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Figure 4. Differential Methylation is Coupled to Differential Gene Expression 
(A) Proportion of differentially expressed genes (DEGs; y-axis) observed among all tested 
genes (control) and among genes associated to MTB-DMRs following infection with MTB.  
(B) Proportion of up- and down-regulated genes associated with hyper and hypo-DMRs. (C) 
GO categories associated with hyper- and hypo-DMRs. 
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Figure S1. General Workflow of Study 
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Table S1. Correlation of Methylation Levels Between DC Samples 
Correlation coefficients were obtained using only CpG sites covered at least in each sample 
and have a minimum coverage of 5. 
 
 
 
 
 
 
 
TB81 TB82 TB83 TB87 TB89 TB91 NI81 NI82 NI83 NI87 NI89 NI91
TB81 0.87 0.87 0.88 0.84 0.85 0.91 0.87 0.87 0.86 0.86 0.87
TB82 0.87 0.87 0.88 0.84 0.85 0.87 0.91 0.86 0.86 0.86 0.87
TB83 0.87 0.87 0.88 0.84 0.85 0.87 0.87 0.90 0.86 0.86 0.87
TB87 0.88 0.88 0.88 0.85 0.86 0.88 0.88 0.87 0.91 0.87 0.88
TB89 0.84 0.84 0.84 0.85 0.82 0.84 0.84 0.83 0.83 0.86 0.84
TB91 0.85 0.85 0.85 0.86 0.82 0.86 0.85 0.85 0.85 0.84 0.88
NI81 0.91 0.87 0.87 0.88 0.84 0.86 0.87 0.87 0.87 0.87 0.88
NI82 0.87 0.91 0.87 0.88 0.84 0.85 0.87 0.86 0.86 0.86 0.87
NI83 0.87 0.86 0.90 0.87 0.83 0.85 0.87 0.86 0.86 0.86 0.87
NI87 0.86 0.86 0.86 0.91 0.83 0.85 0.87 0.86 0.86 0.85 0.87
NI89 0.86 0.86 0.86 0.87 0.86 0.84 0.87 0.86 0.86 0.85 0.86
NI91 0.87 0.87 0.87 0.88 0.84 0.88 0.88 0.87 0.87 0.87 0.86
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Figure S2. Global Trends of DNA Methylation in DCs 
(A) Distribution of genome-wide CpG methylation. 
(B) Relative CpG methylation level with respect to gene-associated regions.  
(C) Violin plots indicate the methylation ratios in regions with different genomic features. 
(D) Hierarchical clustering using Ward’s method based on CpG methylation levels across 
different cell types. Only CpG sites covered at least in each sample and have a minimum 
coverage of 5 were used. 
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Figure S3. Genomic Features of MTB-DMRs 
Boxplots comparing the distribution of the number of CpG sites within hyper- and 
hypomethylated regions. 
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Figure S4. Chromatin Dynamics at Hypermethylated Regions 
Composite plots of patterns of histone marks before and after MTB infection, 3 kb around 
midpoints of hyper-DMRs.  
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Figure S5. Transcriptional Profiles of DC Samples 
Hierarchical clustering of DC samples based on whole-genome gene expression data. 
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4 Conclusion 
Recent advances in epigenomic profiling technologies have expanded our appreciation 
of the importance of dynamic epigenetic mechanisms in regulating transcriptional responses 
to immune challenges. While such epigenetic changes have been well-characterized in patterns 
of different histone marks, it is still not clear to which extent active changes in DNA 
methylation participate in immune responses to immune stimuli. Here, we investigated 
dynamic epigenetic and transcriptional profiles of primary dendritic cell (DC) in response to 
Mycobacterium tuberculosis (MTB) infection. Our results demonstrate that bacterial infection 
rapidly reconfigures the DNA methylation landscape of DCs. Dynamic alterations in DNA 
methylation primarily occur at putative enhancers marked by H3K4me1. Hypomethylated 
regions substantially gain both H3K4me1 and H3K27ac indicative of enhancers becoming 
active after infection. Although we did not observe such dynamic interplay in hypermethylated 
regions, this still suggests that there is a close mechanistic link between DNA methylation and 
histone modifications which is essential in modulating enhancer activity and thus gene 
expression. Consistent with this, we found that dynamic DNA methylation is associated with 
genes that are differentially expressed after MTB infection. In concert, these findings provide 
evidence that changes in DNA methylation at distal regulatory regions are potentially 
implicated in regulating immune responses to bacterial infection
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